Literature DB >> 36033430

Assessment of Alcohol and Other Substance Use in Patients With Chronic Liver Disease.

Rachel L Bachrach1,2,3, Shari S Rogal1,4.   

Abstract

Content available: Audio Recording. Published 2022. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Year:  2022        PMID： 36033430      PMCID： PMC9405514          DOI： 10.1002/cld.1203

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  34 in total

1.  Alcohol Use in Patients with Chronic Liver Disease.

Authors:  Daniel Fuster; Jeffrey H Samet
Journal:  N Engl J Med       Date:  2018-12-27       Impact factor: 91.245

2.  Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.

Authors:  Susan J Curry; Alex H Krist; Douglas K Owens; Michael J Barry; Aaron B Caughey; Karina W Davidson; Chyke A Doubeni; John W Epling; Alex R Kemper; Martha Kubik; C Seth Landefeld; Carol M Mangione; Michael Silverstein; Melissa A Simon; Chien-Wen Tseng; John B Wong
Journal:  JAMA       Date:  2018-11-13       Impact factor: 56.272

3.  Detecting alcoholism. The CAGE questionnaire.

Authors:  J A Ewing
Journal:  JAMA       Date:  1984-10-12       Impact factor: 56.272

4.  Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.

Authors:  Jessica L Mellinger; G Scott Winder; Melissa DeJonckheere; Robert J Fontana; Michael L Volk; Anna S F Lok; Frederic C Blow
Journal:  J Subst Abuse Treat       Date:  2018-05-18

5.  Improving the efficiency of drug use disorder screening in psychiatric settings: validation of a single-item screen.

Authors:  Bridget A Hearon; Casey L Pierce; Thröstur Björgvinsson; Garrett M Fitzmaurice; Shelly F Greenfield; Roger D Weiss; Alisa B Busch
Journal:  Am J Drug Alcohol Abuse       Date:  2015-03       Impact factor: 3.829

6.  Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.

Authors:  Lauren A Beste; Steven L Leipertz; Pamela K Green; Jason A Dominitz; David Ross; George N Ioannou
Journal:  Gastroenterology       Date:  2015-08-05       Impact factor: 22.682

7.  Characteristics of Opioid Prescriptions to Veterans With Cirrhosis.

Authors:  Shari S Rogal; Lauren A Beste; Ada Youk; Michael J Fine; Bryan Ketterer; Hongwei Zhang; Steven Leipertz; Maggie Chartier; Chester B Good; Kevin L Kraemer; Matthew Chinman; Timothy Morgan; Walid F Gellad
Journal:  Clin Gastroenterol Hepatol       Date:  2018-10-17       Impact factor: 11.382

8.  Marijuana use in potential liver transplant candidates.

Authors:  D N Ranney; W B Acker; S N Al-Holou; L Ehrlichman; D S Lee; S A Lewin; C Nguyen; S F Peterson; K Sell; J Kubus; D Reid; M J Englesbe
Journal:  Am J Transplant       Date:  2008-11-27       Impact factor: 8.086

9.  Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Lisa B VanWagner; Hongyan Ning; Norrina B Allen; Veeral Ajmera; Cora E Lewis; John Jeffrey Carr; Donald M Lloyd-Jones; Norah A Terrault; Juned Siddique
Journal:  Gastroenterology       Date:  2017-08-09       Impact factor: 33.883

10.  Cannabis use history is associated with increased prevalence of ascites among patients with nonalcoholic fatty liver disease: A nationwide analysis.

Authors:  Catherine J Choi; Stanley H Weiss; Umair M Nasir; Nikolaos T Pyrsopoulos
Journal:  World J Hepatol       Date:  2020-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.